Skip to content

Staar Surgical STAA Free cash flow yield

Free cash flow yield at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
3%-2.1pp
Bausch Health Companies logo
Bausch Health CompaniesBHC
51.4%-0.2pp
IAR
Integra LifeSciencesIART
2.6%-2.1pp
ITG
Integer HoldingsITGR
3.3%+0.6pp
Glaukos logo
GlaukosGKOS
-1%-0.3pp
HRO
HarrowHROW
1.2%+1.0pp

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.44B+77.9%
Enterprise value$1.35B+100.0%
P/S+2.1×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Calculated from Staar Surgical’s reported figures.

Based on trailing twelve months.

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Staar Surgical's free cash flow yield?
Staar Surgical (STAA) reported free cash flow yield of -4.3% in Q1 2026.
How has Staar Surgical's free cash flow yield changed year-over-year?
Staar Surgical's free cash flow yield decreased by 22.9% year-over-year, from -3.5% to -4.3%.
What is the long-term trend for Staar Surgical's free cash flow yield?
Over 4 years (2020 to 2025), Staar Surgical's free cash flow yield has grown at a 104.2% compound annual growth rate (CAGR), from 0.3% to -4.5%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.